Onconova Therapeutics posted an updated Investor Presentation for January 2020. The presentation is embedded below:...
Tandem Diabetes Care (NASDAQ: TNDM) announced the commercial launch of their new t:slim X2 insulin pump with Control-IQ technology, which helps stabilize blood sugar levels with the help of an automated insulin dosing system...
TransEnterix (NYSE: TRXC) is up more than 50% in early trading as the company announced that they've filed a 510(k) submission with an Intelligent Surgical Unit (ISUTM)1 that is designed to enable machine vision capabilities on the Senhance Surgical System...
After fake news attacks, and constant attacks by short sellers, Amarin investors finally woke up to some great news on Monday morning as AstraZeneca and Acasti Pharma both announced surprisingly disappointing study results for their fish oil products...
Below is the Sci-B-Vac CONSTANT Phase III Top-Line Data Presentation ...
Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2019 financial results...
TransEnterix (NYSE American:TRXC) announced a deal with Ochsner Health System for their Senhance System. The surgical robot will be installed at the Ochsner Baptist facility under a lease agreement, which is typical for hospital systems...
VBI Vaccines Inc. (NASDAQ: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today reported top-line data from CONSTANT...
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful difference to people affected by neurological diseases...
Amarin Corporation plc (NASDAQ:AMRN), today provided a business update, including an update of preliminary 2019 results and additional 2020 financial guidance...